Lung Cancer Targets and Therapy
Latest Publications

TOTAL DOCUMENTS

152
(FIVE YEARS 41)

H-INDEX

7
(FIVE YEARS 3)

Published By Dove Medical Press

1179-2728
Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

scholarly journals Immunotherapy for Stage III NSCLC: Durvalumab and Beyond

2021 ◽  
Vol Volume 12 ◽  
pp. 123-131
Author(s):  
Orla Fitzpatrick ◽  
Jarushka Naidoo
Keyword(s):  
Stage Iii ◽  
Stage Iii Nsclc

scholarly journals Spotlight on Trastuzumab Deruxtecan (DS-8201,T-DXd) for HER2 Mutation Positive Non-Small Cell Lung Cancer

2021 ◽  
Vol Volume 12 ◽  
pp. 103-114
Author(s):  
Ibrahim Azar ◽  
Samer Alkassis ◽  
Jami Fukui ◽  
Fares Alsawah ◽  
Kalub Fedak ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Her2 Mutation

scholarly journals An Update on the Use of Exhaled Breath Analysis for the Early Detection of Lung Cancer

2021 ◽  
Vol Volume 12 ◽  
pp. 81-92
Author(s):  
Nir Peled ◽  
Vered Fuchs ◽  
Emily H Kestenbaum ◽  
Elron Oscar ◽  
Raul Bitran
Keyword(s):  
Lung Cancer ◽  
Early Detection ◽  
Breath Analysis ◽  
Exhaled Breath ◽  
Exhaled Breath Analysis

scholarly journals Targeting AXL in NSCLC

2021 ◽  
Vol Volume 12 ◽  
pp. 67-79
Author(s):  
Aubhishek Zaman ◽  
Trever G Bivona

scholarly journals Spotlight on Mobocertinib (TAK-788) in NSCLC with EGFR Exon 20 Insertion Mutations

2021 ◽  
Vol Volume 12 ◽  
pp. 61-65
Author(s):  
Shannon S Zhang ◽  
Viola W Zhu
Keyword(s):  
Exon 20 ◽  
Insertion Mutations
Load More ...
Sign in / Sign up

Export Citation Format

Share Document